일루시아(ELUT)는 NAS에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $0.85 (+0.00%), 시가총액 $48.63M, 52주 범위 $0.51 ~ $2.46.
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction.
일루시아의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
일루시아의 현재 주가는 $0.85 (+0.00%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
일루시아의 시가총액은 약 $48.63M입니다.
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications.